|Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association|
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ...
Circulation 127 (1), 143-152, 2013
|Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association|
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Circulation 131 (4), 434-441, 2015
|From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I|
M Naghavi, P Libby, E Falk, SW Casscells, S Litovsky, J Rumberger, ...
circulation 108 (14), 1664-1672, 2003
|2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on …|
RA Nishimura, CM Otto, RO Bonow, BA Carabello, JP Erwin, RA Guyton, ...
Journal of the American College of Cardiology 63 (22), e57-e185, 2014
|2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association task …|
P Greenland, JS Alpert, GA Beller, EJ Benjamin, MJ Budoff, ZA Fayad, ...
Journal of the American College of Cardiology 56 (25), e50-e103, 2010
|American Heart Association statistics committee and stroke statistics subcommittee|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Heart disease and stroke statistics-2017 update: a report from the American …, 2017
|Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium|
MB Leon, N Piazza, E Nikolsky, EH Blackstone, DE Cutlip, AP Kappetein, ...
Journal of the American College of Cardiology 57 (3), 253-269, 2011
|ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from …|
AT Hirsch, ZJ Haskal, NR Hertzer, CW Bakal, MA Creager, JL Halperin, ...
Journal of the American College of Cardiology 47 (6), e1-e192, 2006
|Atherothrombosis and high-risk plaque: part I: evolving concepts|
V Fuster, PR Moreno, ZA Fayad, R Corti, JJ Badimon
Journal of the American College of Cardiology 46 (6), 937-954, 2005
|Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound|
AW Leber, A Becker, A Knez, F von Ziegler, M Sirol, K Nikolaou, ...
Journal of the American College of Cardiology 47 (3), 672-677, 2006
|From vulnerable plaque to vulnerable patient—part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report|
M Naghavi, E Falk, HS Hecht, MJ Jamieson, S Kaul, D Berman, Z Fayad, ...
The American journal of cardiology 98 (2), 2-15, 2006
|Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging|
ZA Fayad, V Fuster, JT Fallon, T Jayasundera, SG Worthley, G Helft, ...
Circulation 102 (5), 506-510, 2000
|Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model|
Q Sun, A Wang, X Jin, A Natanzon, D Duquaine, RD Brook, ...
Jama 294 (23), 3003-3010, 2005
|Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport|
RS Rosenson, HB Brewer Jr, WS Davidson, ZA Fayad, V Fuster, ...
Circulation 125 (15), 1905-1919, 2012
|Clinical imaging of the high-risk or vulnerable atherosclerotic plaque|
ZA Fayad, V Fuster
Circulation research 89 (4), 305-316, 2001
|Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging|
R Corti, ZA Fayad, V Fuster, SG Worthley, G Helft, J Chesebro, M Mercuri, ...
Circulation 104 (3), 249-252, 2001
|Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years’ follow-up by high-resolution noninvasive magnetic resonance imaging|
R Corti, V Fuster, ZA Fayad, SG Worthley, G Helft, D Smith, J Weinberger, ...
Circulation 106 (23), 2884-2887, 2002
|Imaging of atherosclerotic cardiovascular disease|
J Sanz, ZA Fayad
Nature 451 (7181), 953, 2008
|Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial|
ZA Fayad, V Mani, M Woodward, D Kallend, M Abt, T Burgess, V Fuster, ...
The Lancet 378 (9802), 1547-1559, 2011
|Multifunctional gold nanoparticles for diagnosis and therapy of disease|
AJ Mieszawska, WJM Mulder, ZA Fayad, DP Cormode
Molecular pharmaceutics 10 (3), 831-847, 2013